An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi

Abstract excerpt

BACKGROUND: Recently, a 23-gene signature was developed to produce a melanoma diagnostic score capable of differentiating malignant and benign melanocytic lesions. The primary objective of this study was to independently assess the ability of the gene signature to differentiate melanoma from benign nevi in clinically relevant lesions. METHODS: A set of 1400 melanocytic lesions was selected from samples...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cutaneous Melanoma Detection and Management
• Share to Melanoma and MAPK Pathways
• Share to Nonmelanoma Skin Cancer Studies